These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8249953)

  • 1. Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization.
    Grosheide PM; del Canho R; Heijtink RA; Nuijten AS; Zwijnenberg J; Bänffer JR; Wladimiroff YW; Botman MJ; Mazel JA; de Gast GC
    Am J Dis Child; 1993 Dec; 147(12):1316-20. PubMed ID: 8249953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
    Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
    Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
    Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
    Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
    Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P
    Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen.
    Lee PI; Lee CY; Huang LM; Chang MH
    J Pediatr; 1995 May; 126(5 Pt 1):716-21. PubMed ID: 7751994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of screening for hepatitis B surface antigen during pregnancy in a population with a high prevalence of hepatitis B surface antigen-positive/hepatitis B e antigen-negative carriers.
    Zamir C; Dagan R; Zamir D; Rishpon S; Fraser D; Rimon N; Ben Porath E
    Pediatr Infect Dis J; 1999 Mar; 18(3):262-6. PubMed ID: 10093949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand.
    Lolekha S; Warachit B; Hirunyachote A; Bowonkiratikachorn P; West DJ; Poerschke G
    Vaccine; 2002 Nov; 20(31-32):3739-43. PubMed ID: 12399203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of hepatitis B immune globulin in prevention of perinatal transmission of the hepatitis B virus.
    Nair PV; Weissman JY; Tong MJ; Thursby MW; Paul RH; Henneman CE
    Gastroenterology; 1984 Aug; 87(2):293-8. PubMed ID: 6376265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen.
    Schalm SW; Mazel JA; de Gast GC; Heijtink RA; Botman MJ; Bänffer JR; Cerards LJ; Zwijnenberg J; Fetter WP; Nuijten SM
    Pediatrics; 1989 Jun; 83(6):1041-8. PubMed ID: 2726331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area.
    Esteban JI; Genesca J; Esteban R; Hernandez JM; Seijo G; Buti M; Muniz R; Guardia J
    J Med Virol; 1986 Apr; 18(4):381-91. PubMed ID: 2940334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
    Farmer K; Gunn T; Woodfield DG
    N Z Med J; 1987 Jul; 100(827):412-4. PubMed ID: 2967932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of hepatitis B by immunization of the newborn infant--a long-term follow-up study in Stockholm, Sweden.
    Sangfelt P; Reichard O; Lidman K; von Sydow M; Forsgren M
    Scand J Infect Dis; 1995; 27(1):3-7. PubMed ID: 7784811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
    Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
    BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.
    Wang Z; Zhang J; Yang H; Li X; Wen S; Guo Y; Sun J; Hou J
    J Med Virol; 2003 Nov; 71(3):360-6. PubMed ID: 12966540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
    Lee CY; Huang LM; Chang MH; Hsu CY; Wu SJ; Sung JL; Safary A
    Pediatr Infect Dis J; 1991 Apr; 10(4):299-303. PubMed ID: 1829515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive-active immunisation of neonates of HBsAg positive carrier mothers: preliminary observations.
    Mazel JA; Schalm SW; de Gast BC; Nuijten AS; Heijtink RA; Botman MJ; Bänffer JR; Gerards LJ; Zwijnenberg J; Mettau J
    Br Med J (Clin Res Ed); 1984 Feb; 288(6416):513-5. PubMed ID: 6421359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1986 Jun; 4(1):33-6. PubMed ID: 3730058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity.
    del Canho R; Grosheide PM; Mazel JA; Heijtink RA; Hop WC; Gerards LJ; de Gast GC; Fetter WP; Zwijneberg J; Schalm SW
    Vaccine; 1997 Oct; 15(15):1624-30. PubMed ID: 9364693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.